Leadership

From Compendium of Cancer Genome Aberrations
Revision as of 15:19, 2 August 2021 by Jennelleh (talk | contribs)
Jump to navigation Jump to search

Meet your editors! We welcome questions and your participation in the CCGA.

Jennelle C. Hodge, PhD, FACMG, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; Editor-in-Chief CCGA
Fabiola-Quintero-Rivera, MD, Professor, Departments of Pathology and Laboratory Medicine and Pediatrics, University of California Irvine; Associate Editor CCGA [MDS/MPN Section]
Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; Associate Editor CCGA [ALL Section]
Snehal Patel, MD, PhD; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]
Greg Corboy, PhD, Pathology Queensland (Queensland, Australia) School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Hodgkin Lymphomas/Lymphoproliferative Disorders/Other Rare Entities Section]
Malini Sathanoori, PhD, FACMG, Associate Director, Clinical Cytogenetics, FISH and Microarray Services, PathGroup; Associate Editor CCGA [AML Section]
Alanna Church, MSc, MD, FRCPC, Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Boston Children’s Hospital, Assistant Professor of Pathology, Harvard Medical School; Associate Editor CCGA [Gene-Specific Section]